Biogen Alzheimer's Drug Could Get Medicare Coverage In 2025 If Approved, Says Dr. Scott Gottlieb

Biogen Alzheimer's drug could get Medicare coverage in 2025 if approved, says Dr. Scott Gottlieb

CNBC Television

Scott Gottlieb on FDA approval of Alzheimer's drug Leqembi: It will help get more people diagnosed

CNBC Television

That Pricey New Alzheimer's Drug? Still Not Great

Healthcare Triage

Biogen $BIIB & Eisai $ESALY FDA Decision on Alzheimer's Drug Lecanemab: Stock will go up or down 40%

MoneyPigTrading

First new drug for Alzheimer's in 20 years approved by FDA

Medicare will cover Biogen's $28K Alzheimer's drug, only in trials

CNBC Television

Medicare Will Cover Cost Of Biogen's Alzheimer's Drug For Patients In Trials

FDA approves Biogen Alzheimer's drug, first new therapy for the disease in nearly two decades

CNBC Television

Medicare to restrict coverage of Biogen’s Alzheimer’s drug

Biogen shares fall after it scraps Alzheimer's treatment

CNBC Television

FDA approves Biogen's Alzheimer's drug

CNBC Television

Biogen's Alzheimer's Drug Coverage Limited by U.S.

Bloomberg Television

FDA approves Alzheimer's drug that modestly slows disease

US Officials OK Alzheimer's drug

Associated Press

Former FDA Administrator Dr. Scott Gottlieb | Expanding Access to Alzheimer’s Care & Treatment

The Hill Events

Analyst: It's unclear whether Biogen's new Alzheimer's drug will get approved

CNBC Television

Biogen Alzheimer's drug may be 'first effort of a clear win': Analyst

FDA approves Biogen's Alzheimer's drug

US approves Alzheimer's drug that modestly slows disease

FDA approves Alzheimer's drug from Cambridge-based Biogen

WCVB Channel 5 Boston